InsiderSignal.AI

InsiderSignal.ai

PRLD - Prelude Therapeutics Inc

Insider Purchase by Bonita David P (Dir, 10%)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

3 days ago, Bonita David P, serving as Dir, 10% owner at Prelude Therapeutics Inc (PRLD), purchased 2,815,315 shares at $4.44 per share, for a total transaction value of $12,499,999.00. Following this transaction, Bonita David P now holds 1,652,426 shares of PRLD.

This purchase represents a 242.00% decrease in Bonita David P's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, April 21, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, April 23, 2026, 2 days after the trade was made.

Prelude Therapeutics Inc operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Bonita David P

Dir, 10%

David P. Bonita, M.D. is a seasoned healthcare investor and board director, currently serving as an Independent Director at ImageneBio, Inc. (IMA) since 2025, alongside roles at Acutus Medical, Inc. (since 2016), Prelude Therapeutics, Inc. (since 2016), Repare Therapeutics, Inc. (since 2019), Third Harmonic Bio, Inc. (since 2020), and others, including as General Partner at OrbiMed Advisors Private Equity since 2020.[[1]](https://www.marketscreener.com/insider/DAVID-BONITA-A077UI/)[[3]](https://preludetx.com/david-bonita-md/)[[4]](https://imagenebio.com/team/david-p-bonita-m-d/) Dr. Bonita previously held directorships at companies such as Tricida, Inc. (until 2023), SI-BONE, Inc. (2014-2019), and Loxo Oncology, Inc. (2013-2017), and began his career as a corporate finance analyst in healthcare investment banking at Morgan Stanley and UBS.[[1]](https://www.marketscreener.com/insider/DAVID-BONITA-A077UI/)[[3]](https://preludetx.com/david-bonita-md/)[[4]](https://imagenebio.com/team/david-p-bonita-m-d/) He holds an A.B. in Biological Sciences from Harvard University (1997) and joint M.D./M.B.A. degrees from Columbia University (2004).[[1]](https://www.marketscreener.com/insider/DAVID-BONITA-A077UI/)[[3]](https://preludetx.com/david-bonita-md/)[[4]](https://imagenebio.com/team/david-p-bonita-m-d/)

View full insider profile →

Trade Price

$4.44

Quantity

2,815,315

Total Value

$12,499,999.00

Shares Owned

1,652,426

Trade Date

Tuesday, April 21, 2026

3 days ago

SEC Filing Date

Thursday, April 23, 2026

Filed 2 days after trade

HEALTHCAREBIOTECHNOLOGY

About Prelude Therapeutics Inc

Company Overview

No company information available
View news mentioning PRLD

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/5882754

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime